Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 1

Synthesis and evaluation of new imidazo[2,1-b]thiazoles as antituberculosis agents

Pages
102–109
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Among the synthesized compounds [6-(4-bromophenyl)imidazo[2,1-b] thiazol-3-yl]acetic acid 2,4-dinitrobenzylidenehydrazide (3e) was found to be the most active compound in vitro with MIC of 6.25 mg/ml.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:New N’-(arylidene)-2-[6-(4-bromophenyl)imidazo[2,1-b] thiazol-3-yl]acetohydrazides (3a-i) were synthesized by reacting 2-[6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl] acetohydrazide with different aromatic aldehydes.
📊
Key Findings & Data:The structures of the title compounds were established by spectral data (IR, 1H NMR, 13C NMR) and elemental analyses.
💡
Conclusion & Impact:Among the synthesized compounds [6-(4-bromophenyl)imidazo[2,1-b] thiazol-3-yl]acetic acid 2,4-dinitrobenzylidenehydrazide (3e) was found to be the most active compound in vitro with MIC of 6.25 mg/ml.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

New N’-(arylidene)-2-[6-(4-bromophenyl)imidazo[2,1-b] thiazol-3-yl]acetohydrazides (3a-i) were synthesized by reacting 2-[6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl] acetohydrazide with different aromatic aldehydes. The structures of the title compounds were established by spectral data (IR, 1H NMR, 13C NMR) and elemental analyses. The synthesized compounds were evaluated for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv employing the BACTEC 460 radiometric system. The compounds exhibited varying degrees of inhibition in the in vitro primary screening that was conducted at a concentration of 6.25 mg/ml. Among the synthesized compounds [6-(4-bromophenyl)imidazo[2,1-b] thiazol-3-yl]acetic acid 2,4-dinitrobenzylidenehydrazide (3e) was found to be the most active compound in vitro with MIC of 6.25 mg/ml.

🔖

Cite This Article

GÜZELDEMİRCİ, N. U., GÜRSOY, E. (2017). Synthesis and evaluation of new imidazo[2,1-b]thiazoles as antituberculosis agents. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 1, 102–109. https://ajindex.com/articles/283708

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gürsoy A, Demirayak Ş, Cesur Z, Reisch J, Ötük G. Synthesis of some hydrazide-hydrazones, thiosemicarbazides, thiadiazoles, triazoles and their derivatives as possible antimicrobiales. Pharmazie 1990; 45: 246-50.
  2. Çapan G, Ulusoy N, Ergenç N, Kiraz M. New 6-phenylimidazo[2,1-b]thiazole derivatives: Synthesis and antifungal activity. Monatsh Chem 1999; 130: 1399-1407.
  3. Gürsoy E, Ulusoy Güzeldemirci N. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 2007; 42: 320-6.
  4. Harraga S, Nicod L, Drouhin JP, Xicluna A, Panouse JJ, Seilles E, Robert JF. Imidazo[2,1-b]thiazole derivatives. XI. Modulation of the CD2-receptor of human T trypsinized lymphocytes by several imidazo[2,1-b]thiazoles. Eur J Med Chem 994; 29: 309-15.
  5. Robert JF, Xicluna A, Panouse JJ. Advances in heterocyclic chemistry. Eur J Med Chem Chim Ther 1975; 10: 59-64.
  6. Inderlied CB, Nash KA. Antimycobacterial Agents: In Vitro Susceptibility Testing and Mechanisms of Action and Resistance. In: Antibiotics in Laboratory Medicine. 5th ed. Editor: Lorian V. Lippincott-Williams & Wilkins, Philadelphia. 2005, p. 155. Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41: 1004-9.
  7. Kühmstedt H, Kottke K, Knoke D, Robert JF, Panouse JJ. Synthesis of amides and heterocyclic acylhydrazides with potential immunomodulator properties. Ann Pharm Fr 1983; 40: 425-9.
  8. Robert JF, Boukraa S, Panouse JJ, Loppinet V, Chaumont JP. Dérivés de l’imidazo[2,1-b]thiazole X. Propriétés fongistatiques de 2-aminothiazoles et de 6-aryl imidazo[2,1-b] thiazoles s ubstitués respectivement en 4 et en 3 par un reste aryléthyle, aroylméthyle, β-hydroxy β-aryléthyle et et éthoxycarbonylméthyle. Eur J Med Chem 1990; 25: 731-6.
  9. Ulusoy N, Küçükbasmacı Ö. Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur J Med Chem 2010; 45: 63-8.
  10. Ulusoy N, Kiraz M, Küçükbasmacı Ö. New 6-(4-bromophenyl)imidazo[2, 1- b] thiazole derivatives: Synthesis and antimicrobial activity. Monatsh Chem 2002; 133: 1305-15.
  11. Ulusoy, N. Synthesis and antituberculosis activity of cycloalkylidenehydrazide and 4- aza-1-thiaspiro[4.5] decan-3-one derivatives of imidazo[2, 1- b] thiazole. Arzneim- Forsch/Drug Res 2002; 52: 565-71.
  12. Ulusoy N, Çapan G, Ötük G, Kiraz M. Synthesis and anti